In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
Griffith University researchers are making inroads in ovarian cancer research looking at early detection signs and how the disease spreads through the body.
Dr Ellie Martus, Centre for Governance and Public Policy Griffith University, and Associate Professor Fengshi Wu, University of New South...
Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.
The ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and improve treatment options for women.
Griffith University researchers have discovered a new Hendra virus variant that may pass to horses and humans much more widely across Australia than previously known.
The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Griffith University researchers are conducting a world-leading trial assessing the role of exercise as therapy for women with recurrent ovarian cancer
Broad-spectrum malaria vaccine can be freeze-dried making it suitable for deployment into malaria-endemic countries.
Living through a global pandemic over the past year has seen all of us expanding our vocabularies. We now understand terms like PPE, social distancing and contact tracing. But just when perhaps we thought we had a handle on most of the terminology, we’re faced with another set of new words: mutation, variant and strain.
